Microglial transglutaminase-2 drives myelination and myelin repair via GPR56/ADGRG1 in oligodendrocyte precursor cells

  1. Stefanie Giera
  2. Rong Luo
  3. Yanqin Ying
  4. Sarah D Ackerman
  5. Sung-Jin Jeong
  6. Hannah M Stoveken
  7. Christopher J Folts
  8. Christina A Welsh
  9. Gregory G Tall
  10. Beth Stevens
  11. Kelly R Monk  Is a corresponding author
  12. Xianhua Piao  Is a corresponding author
  1. Boston Children's Hospital, United States
  2. Washington University School of Medicine, United States
  3. University of Michigan Medical Center, United States

Abstract

In the central nervous system (CNS), myelin formation and repair are regulated by oligodendrocyte (OL) lineage cells, which sense and integrate signals from their environment, including from other glial cells and the extracellular matrix (ECM). The signaling pathways that coordinate this complex communication, however, remain poorly understood. The adhesion G protein-coupled receptor ADGRG1 (also known as ADGRG1) is an evolutionarily conserved regulator of OL development in humans, mice, and zebrafish, although its activating ligand for OL lineage cells is unknown. Here, we report that microglia-derived transglutaminase-2 (TG2) signals to ADGRG1 on OL precursor cells (OPCs) in the presence of the ECM protein laminin and that TG2/laminin-dependent activation of ADGRG1 promotes OPC proliferation. Signaling by TG2/laminin to ADGRG1 on OPCs additionally improves remyelination in two murine models of demyelination. These findings identify a novel glia-to-glia signaling pathway that promotes myelin formation and repair, and suggest new strategies to enhance remyelination.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Stefanie Giera

    Division of Newborn Medicine, Department of Medicine, Boston Children's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  2. Rong Luo

    Division of Newborn Medicine, Department of Medicine, Boston Children's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  3. Yanqin Ying

    Division of Newborn Medicine, Department of Medicine, Boston Children's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  4. Sarah D Ackerman

    Department of Developmental Biology, Washington University School of Medicine, St. Louis, United States
    Competing interests
    No competing interests declared.
  5. Sung-Jin Jeong

    Division of Newborn Medicine, Department of Medicine, Boston Children's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
  6. Hannah M Stoveken

    Department of Pharmacology, University of Michigan Medical Center, Ann Arbor, United States
    Competing interests
    No competing interests declared.
  7. Christopher J Folts

    Division of Newborn Medicine, Department of Medicine, Boston Children's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0448-3711
  8. Christina A Welsh

    FM Kirby Neurobiology Center, Boston Children's Hospital, Boston, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9802-725X
  9. Gregory G Tall

    Department of Pharmacology, University of Michigan Medical Center, Ann Arbor, United States
    Competing interests
    No competing interests declared.
  10. Beth Stevens

    FM Kirby Neurobiology Center, Boston Children's Hospital, Boston, United States
    Competing interests
    Beth Stevens, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4226-1201
  11. Kelly R Monk

    Department of Developmental Biology, Washington University School of Medicine, St. Louis, United States
    For correspondence
    monkk@wustl.edu
    Competing interests
    No competing interests declared.
  12. Xianhua Piao

    Division of Newborn Medicine, Department of Medicine, Boston Children's Hospital, Boston, United States
    For correspondence
    Xianhua.Piao@childrens.harvard.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7540-6767

Funding

National Institute of Neurological Disorders and Stroke (NS094164)

  • Xianhua Piao

National Multiple Sclerosis Society (RG-1501-02577)

  • Xianhua Piao

National Institute of Neurological Disorders and Stroke (NS08520)

  • Xianhua Piao

National Institute of Neurological Disorders and Stroke (NS079445)

  • Kelly R Monk

National Multiple Sclerosis Society (FG 2063-A1/2)

  • Stefanie Giera

National Multiple Sclerosis Society (Harry Weaver Neuroscience Fellowship)

  • Kelly R Monk

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in accordance to the guidelines of the Animal Care and Use Committee (IACUC) protocols (17-12-3578R and 17-03-3378R) at Boston Children's Hospital. Zebrafish experiments were performed in compliance with Washington University's Institutional Animal Care and Use Committee (IACUC) protocol (20160174)

Copyright

© 2018, Giera et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,670
    views
  • 709
    downloads
  • 100
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Stefanie Giera
  2. Rong Luo
  3. Yanqin Ying
  4. Sarah D Ackerman
  5. Sung-Jin Jeong
  6. Hannah M Stoveken
  7. Christopher J Folts
  8. Christina A Welsh
  9. Gregory G Tall
  10. Beth Stevens
  11. Kelly R Monk
  12. Xianhua Piao
(2018)
Microglial transglutaminase-2 drives myelination and myelin repair via GPR56/ADGRG1 in oligodendrocyte precursor cells
eLife 7:e33385.
https://doi.org/10.7554/eLife.33385

Share this article

https://doi.org/10.7554/eLife.33385

Further reading

    1. Neuroscience
    Eleni Hackwell, Sharon R Ladyman ... David R Grattan
    Research Article

    The specific role that prolactin plays in lactational infertility, as distinct from other suckling or metabolic cues, remains unresolved. Here, deletion of the prolactin receptor (Prlr) from forebrain neurons or arcuate kisspeptin neurons resulted in failure to maintain normal lactation-induced suppression of estrous cycles. Kisspeptin immunoreactivity and pulsatile LH secretion were increased in these mice, even in the presence of ongoing suckling stimulation and lactation. GCaMP fibre photometry of arcuate kisspeptin neurons revealed that the normal episodic activity of these neurons is rapidly suppressed in pregnancy and this was maintained throughout early lactation. Deletion of Prlr from arcuate kisspeptin neurons resulted in early reactivation of episodic activity of kisspeptin neurons prior to a premature return of reproductive cycles in early lactation. These observations show dynamic variation in arcuate kisspeptin neuronal activity associated with the hormonal changes of pregnancy and lactation, and provide direct evidence that prolactin action on arcuate kisspeptin neurons is necessary for suppressing fertility during lactation in mice.

    1. Neuroscience
    Choongheon Lee, Mohammad Shokrian ... Jong-Hoon Nam
    Research Article

    We hypothesized that active outer hair cells drive cochlear fluid circulation. The hypothesis was tested by delivering the neurotoxin, kainic acid, to the intact round window of young gerbil cochleae while monitoring auditory responses in the cochlear nucleus. Sounds presented at a modest level significantly expedited kainic acid delivery. When outer-hair-cell motility was suppressed by salicylate, the facilitation effect was compromised. A low-frequency tone was more effective than broadband noise, especially for drug delivery to apical locations. Computational model simulations provided the physical basis for our observation, which incorporated solute diffusion, fluid advection, fluid–structure interaction, and outer-hair-cell motility. Active outer hair cells deformed the organ of Corti like a peristaltic tube to generate apically streaming flows along the tunnel of Corti and basally streaming flows along the scala tympani. Our measurements and simulations coherently suggest that active outer hair cells in the tail region of cochlear traveling waves drive cochlear fluid circulation.